secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001193125-23-138953
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal ups ATM equity facility by $200M to raise additional capital via Cowen
-------------------------------------------------------------------------------

- Amendment to Sales Agreement with Cowen increases ATM capacity by $200M.
- Shares sold through 'at-the-market' offerings under existing shelf registration.
- Company has no obligation to sell; Cowen acts as agent on commercially reasonable efforts.
- Prospectus supplement filed May 9, 2023 for the additional $200M of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/0001193125-23-138953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/d416547d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-138953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer